ORGANIZATION OF THE REPORT

This report is organized into five chapters. Chapter 1 describes the statement of task, the committee process, and the purpose for performing the study and provides a brief overview of the amorphous nature of the threat and challenges the CBDP faces. Chapter 2 discusses the CBDP mission and the various frameworks that the CBDP organizational elements use to address their areas of responsibility. The chapter goes on to discuss the committee’s view of the mission and introduces the Science and Technology (S&T) Capability Categories that it has identified in order to address the statement of task. Chapter 3 describes core S&T capabilities that are necessary for the CBDP and considers where these capabilities may best be obtained.

In Chapter 4 the committee discusses a strategic capabilities-based planning approach the CBDP could adopt as a way to unify the various program elements around a single set of needs for the program. Chapter 5 discusses the importance of relationships with the end users and the research-development-acquisition (R-D-A) transition, and makes some comments and suggestions for long-term management of the CBDP S&T program, including discussion geared toward the individual DoD laboratories, with the aim of sustaining the core capabilities. Findings and recommendations are found at the end of each chapter and in the Summary.

THE COMMITTEE PROCESS

The committee was asked by DoD to perform this study under stringent time constraints. Over a period of approximately three months, the committee gathered information through a series of briefings, site visits, and interviews with individuals and groups, including stakeholders in the CBDP and operators that rely on the CBDP to support their missions. These included DoD Laboratory personnel; Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD), Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD), and Joint Requirements Office for Chemical, Biological, Radiological, and Nuclear Defense (JRO-CBRND) personnel; CBDP customers, including some US Combatant Commands (COCOMs) and Services; and representatives from organizations and agencies within the broader CBD community, including Cooperative Threat Reduction (CTR) and Global Emerging Infections Surveillance and Response System (GEIS) within DoD, as well as representatives from the Department of Homeland Security (DHS) and the Department of Health and Human Service (HHS).

In addition to the formal briefings and roundtable discussions mentioned above, committee subgroups conducted site visits at US Army Dugway Proving Ground (DPG), US Army Natick Soldier Research,



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement